Recruiting Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks NCT06361537 Conditions Acute Hereditary Angio Edema, Angioedema, Cardiovascular Diseases, +11 more Locations Octapharma Research Site — Centennial, Colorado, United States Octapharma Research Site — Farmington Hills, Michigan, United States Octapharma Research Site — Toledo, Ohio, United States Octapharma Research Site — Tirana, Albania View all 23 locations View more locations Show fewer locations Loading locations... View Trial Details
